Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico
Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico
Milan, Italy3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sequential Therapies After Osteoanabolic Treatment | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis | Recruiting | Not stated | 2026-07-22 | NCT06164795 | |
| Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study) | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis | Active, not recruiting | Not stated | 2026-07-22 | NCT05575167 | |
| Study of Acalabrutinib and Tafasitamab in MZL Patients | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-04-06 | NCT04646395 |